Literature DB >> 7003031

Selective vs. nonselective media and direct plating vs. enrichment technique in isolation of Vibrio cholerae: recommendations for clinical laboratories.

M B Rennels, M M Levine, V Daya, P Angle, C Young.   

Abstract

The occurrence of human cholera along the Gulf of Mexico and the isolation of Vibrio cholerae O1 from the Gulf and Chesapeake Bay make it imperative that microbiology laboratories along estuaries develop the capabilities to culture for these pathogens. In attempts to devise a simplified but efficient culture procedure, a selective medium, thiosulfate-citrate-bile salts-sucrose (TCBS) agar, was compared with a nonselective medium, gelatin agar (GA), and the utility of enrichment was examined. TCBS agar detected 99% of the stools found to be positive by all techniques combined, whereas GA identified only 80%. Of acute diarrheal stools, 96% were positive on direct plating, whereas only 66% of formed stools containing V. cholerae were detected by direct plating. Stools from patients with acute diarrhea can be plated directly into TCBS agar alone; stools from persons shedding low numbers of organisms (such as contacts, carriers, or patients receiving antibiotics) should be incubated first in an enrichment broth and then on TCBS agar.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7003031     DOI: 10.1093/infdis/142.3.328

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial.

Authors:  K L Kotloff; S S Wasserman; S O'Donnell; G A Losonsky; S J Cryz; M M Levine
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

2.  Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.

Authors:  Wilbur H Chen; Richard N Greenberg; Marcela F Pasetti; Sofie Livio; Michael Lock; Marc Gurwith; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

3.  Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults.

Authors:  S Migasena; P Pitisuttitham; B Prayurahong; P Suntharasamai; W Supanaranond; V Desakorn; U Vongsthongsri; B Tall; J Ketley; G Losonsky
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

4.  Detection, isolation, and identification of Vibrio cholerae from the environment.

Authors:  Anwar Huq; Bradd J Haley; Elisa Taviani; Arlene Chen; Nur A Hasan; Rita R Colwell
Journal:  Curr Protoc Microbiol       Date:  2012-08

5.  Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.

Authors:  M M Levine; J B Kaper; D Herrington; G Losonsky; J G Morris; M L Clements; R E Black; B Tall; R Hall
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

6.  Viable but non-culturable Vibrio cholerae O1 revert to a cultivable state in the human intestine.

Authors:  R R Colwell; P Brayton; D Herrington; B Tall; A Huq; M M Levine
Journal:  World J Microbiol Biotechnol       Date:  1996-01       Impact factor: 3.312

7.  Comparison of direct-plating and enrichment methods for isolation of Vibrio cholerae from diarrhea patients.

Authors:  M Lesmana; E Richie; D Subekti; C Simanjuntak; S E Walz
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

8.  Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.

Authors:  R E Black; M M Levine; M L Clements; C R Young; A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

9.  New selective and differential medium for Vibrio cholerae and Vibrio vulnificus.

Authors:  G Massad; J D Oliver
Journal:  Appl Environ Microbiol       Date:  1987-09       Impact factor: 4.792

10.  Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine.

Authors:  M M Levine; R E Black; M L Clements; C Lanata; S Sears; T Honda; C R Young; R A Finkelstein
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.